Idera Pharmaceuticals (IDRA) Short Interest Ratio & Short Volume → Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad) Free IDRA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Idera Pharmaceuticals Short Interest DataCurrent Short Volume550,300 sharesPrevious Short Volume668,000 sharesChange Vs. Previous Month-17.62%Dollar Volume Sold Short$235,473.37Short Interest Ratio / Days to Cover4.5Last Record DateOctober 31, 2022Outstanding Shares62,355,000 sharesFloat Size40,900,000 sharesShort Percent of Float1.35%Today's Trading Volume21,870 sharesAverage Trading Volume464,030 sharesToday's Volume Vs. Average5% Short Selling Idera Pharmaceuticals ? Sign up to receive the latest short interest report for Idera Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIDRA Short Interest Over TimeIDRA Days to Cover Over TimeIDRA Percentage of Float Shorted Over Time Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. Idera Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2022550,300 shares $235,473.37 -17.6%1.4%4.5 $0.43 10/15/2022668,000 shares $248,562.80 -9.8%1.7%5.6 $0.37 9/30/2022740,400 shares $277,279.80 +34.5%1.9%7.1 $0.37 9/15/2022550,600 shares $252,615.28 -27.7%1.4%4.9 $0.46 8/31/2022761,900 shares $380,950.00 +8.8%1.9%5.3 $0.50 8/15/2022700,400 shares $308,876.40 -24.7%1.7%2.9 $0.44 Get the Latest News and Ratings for IDRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Idera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/2022929,900 shares $382,560.86 +0.7%2.3%0.9 $0.41 7/15/2022923,800 shares $398,157.80 -0.9%2.3%0.9 $0.43 6/30/2022932,400 shares $427,971.60 -14.5%2.3%0.9 $0.46 6/15/20221,090,000 shares $530,939.00 -37.7%4.9%1 $0.49 5/31/20221,750,000 shares $1.22 million +1,141.1%4.2%1.7 $0.70 5/15/2022141,000 shares $49,448.70 -11.5%0.3%0.1 $0.35 4/30/2022159,400 shares $68,860.80 -61.2%0.4%0.9 $0.43 4/15/2022410,300 shares $188,738.00 -21.5%1.0%2.2 $0.46 3/31/2022522,400 shares $261,200.00 +62.8%N/A0 $0.50 3/15/2022320,800 shares $137,976.08 +26.0%0.8%0.8 $0.43 2/28/2022254,700 shares $110,310.57 -39.6%0.6%0.3 $0.43 2/15/2022421,500 shares $220,486.65 +39.3%1.0%0.4 $0.52 1/31/2022302,700 shares $178,017.87 -52.3%0.7%0.3 $0.59 1/15/2022634,700 shares $415,157.27 +130.3%N/A0.6 $0.65 12/31/2021275,600 shares $157,092.00 -75.8%0.7%0.3 $0.57 12/15/20211,140,000 shares $741,114.00 +588.0%2.8%1.1 $0.65 11/30/2021165,700 shares $107,870.70 -49.7%0.4%0.2 $0.65 11/15/2021329,600 shares $272,315.52 -32.3%0.8%0.7 $0.83 10/29/2021486,700 shares $413,695.00 -4.4%1.2%1 $0.85 10/15/2021508,900 shares $478,366.00 -6.6%1.2%1 $0.94 9/30/2021544,700 shares $561,041.00 -68.3%1.3%1 $1.03 9/15/20211,720,000 shares $1.77 million -25.2%4.2%2.1 $1.03 8/31/20212,300,000 shares $2.51 million -12.9%5.7%1.1 $1.09 8/13/20212,640,000 shares $2.93 million -4.7%6.5%1.2 $1.11 7/30/20212,770,000 shares $2.85 million +10.4%7.2%1.2 $1.03 7/15/20212,510,000 shares $2.54 million -24.9%6.5%1 $1.01 6/30/20213,340,000 shares $4.01 million +2.8%8.7%1.2 $1.20 6/15/20213,250,000 shares $4.00 million -12.2%8.4%1 $1.23 5/28/20213,700,000 shares $4.33 million -0.3%9.6%1.1 $1.17 5/14/20213,710,000 shares $3.75 million +0.3%N/A1.1 $1.01 4/30/20213,700,000 shares $4.37 million -14.0%N/A1.1 $1.18 4/15/20214,300,000 shares $4.86 million -13.8%N/A0 $1.13 3/31/20214,990,000 shares $6.14 million +130.0%N/A1.8 $1.23 3/15/20212,170,000 shares $10.57 million +169.0%N/A1.1 $4.87Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide IDRA Short Interest - Frequently Asked Questions What is Idera Pharmaceuticals' current short interest? Short interest is the volume of Idera Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 550,300 shares of IDRA short. 1.35% of Idera Pharmaceuticals' shares are currently sold short. Learn More on Idera Pharmaceuticals' current short interest. What is a good short interest ratio for Idera Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IDRA shares currently have a short interest ratio of 4.0. Learn More on Idera Pharmaceuticals's short interest ratio. What is a good short interest percentage for Idera Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.35% of Idera Pharmaceuticals' floating shares are currently sold short. Is Idera Pharmaceuticals' short interest increasing or decreasing? Idera Pharmaceuticals saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 550,300 shares, a drop of 17.6% from the previous total of 668,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Idera Pharmaceuticals' float size? Idera Pharmaceuticals currently has issued a total of 62,355,000 shares. Some of Idera Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Idera Pharmaceuticals currently has a public float of 40,900,000 shares. How does Idera Pharmaceuticals' short interest compare to its competitors? 1.35% of Idera Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Idera Pharmaceuticals: iTeos Therapeutics, Inc. (7.19%), Replimune Group, Inc. (17.40%), Jasper Therapeutics, Inc. (3.84%), Ocugen, Inc. (16.95%), Solid Biosciences Inc. (3.05%), Adaptive Biotechnologies Co. (6.57%), Voyager Therapeutics, Inc. (6.13%), Caribou Biosciences, Inc. (12.85%), Monte Rosa Therapeutics, Inc. (5.31%), Aura Biosciences, Inc. (6.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.81 billion), Charter Communications, Inc. ($3.04 billion), T. Rowe Price Group, Inc. ($1.98 billion), PG&E Co. ($1.92 billion), Lucid Group, Inc. ($1.90 billion), Coinbase Global, Inc. ($1.75 billion), Roblox Co. ($1.58 billion), Rivian Automotive, Inc. ($1.54 billion), Diamondback Energy, Inc. ($1.53 billion), and Old Dominion Freight Line, Inc. ($1.47 billion). View all of the most shorted stocks. What does it mean to sell short Idera Pharmaceuticals stock? Short selling IDRA is an investing strategy that aims to generate trading profit from Idera Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Idera Pharmaceuticals? A short squeeze for Idera Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IDRA, which in turn drives the price of the stock up even further. How often is Idera Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IDRA, twice per month. The most recent reporting period available is October, 31 2022. More Short Interest Resources from MarketBeat Related Companies: iTeos Therapeutics Short Squeeze Replimune Group Short Squeeze Jasper Therapeutics Short Squeeze Ocugen Short Squeeze Solid Biosciences Short Squeeze Adaptive Biotechnologies Short Squeeze Voyager Therapeutics Short Squeeze Caribou Biosciences Short Squeeze Monte Rosa Therapeutics Short Squeeze Aura Biosciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IDRA) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative